JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14% |
| 2 | Technology | 12.71% |
| 3 | Healthcare | 9.7% |
| 4 | Consumer Discretionary | 8.65% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
3151
Safehold
SAFE
$1.08B
| $2.37M | ﹤0.01% |
45,047
-26,686
| -37% | -$1.37M |
|
3152
ANI Pharmaceuticals
ANIP
$1.76B
| $2.37M | ﹤0.01% |
35,399
+4,938
| +16% | +$308K |
|
3153
Fidelity Total Bond ETF
FBND
$27.3B
| $2.36M | ﹤0.01% |
48,324
+260
| +0.5% | +$12.7K |
|
3154
CALL
Hartford Financial Services
HIG
$37.8B
| $2.36M | ﹤0.01% |
+46,200
| New | +$2.42M |
|
|
GOGL
3155
DELISTED
Golden Ocean Group
GOGL
| $2.36M | ﹤0.01% |
+271,721
| New | +$2.28M |
|
|
BMTC
3156
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.35M | ﹤0.01% |
50,770
+1,242
| +3% | +$57.4K |
|
|
NXGN
3157
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.35M | ﹤0.01% |
120,281
+48,941
| +69% | +$774K |
|
|
NTUS
3158
DELISTED
Natus Medical Inc
NTUS
| $2.34M | ﹤0.01% |
67,835
-158,044
| -70% | -$5.54M |
|
|
RFP
3159
DELISTED
Resolute Forest Products Inc.
RFP
| $2.34M | ﹤0.01% |
225,913
+158,012
| +233% | +$1.59M |
|
|
ALX
3160
Alexander's
ALX
$1.38B
| $2.34M | ﹤0.01% |
6,105
+5,371
| +732% | +$2.08M |
|
3161
iShares US Medical Devices ETF
IHI
$3.46B
| $2.33M | ﹤0.01% |
69,720
-292,890
| -81% | -$9.54M |
|
|
VNET
3162
VNET Group
VNET
$2.16B
| $2.33M | ﹤0.01% |
239,842
+168,942
| +238% | +$1.2M |
|
3163
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
| $2.31M | ﹤0.01% |
125,169
+4,691
| +4% | +$86.3K |
|
3164
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $2.31M | ﹤0.01% |
95,000
-100,700
| -51% | -$2.05M |
|
3165
Utah Medical Products
UTMD
$226M
| $2.31M | ﹤0.01% |
20,950
-6,303
| -23% | -$658K |
|
3166
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.31M | ﹤0.01% |
+30,000
| New | +$1.94M |
|
|
3167
PUT
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.31M | ﹤0.01% |
+30,000
| New | +$1.94M |
|
|
CZR
3168
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $2.3M | ﹤0.01% |
+215,000
| New | +$2.51M |
|
|
CWBC
3169
Community West Bancshares
CWBC
$708M
| $2.3M | ﹤0.01% |
108,529
+1,760
| +2% | +$36.9K |
|
3170
Sierra Bancorp
BSRR
$532M
| $2.29M | ﹤0.01% |
81,207
-15,423
| -16% | -$435K |
|
|
FARO
3171
DELISTED
Faro Technologies
FARO
| $2.29M | ﹤0.01% |
42,107
+18,808
| +81% | +$1.05M |
|
3172
Viridian Therapeutics
VRDN
$2.5B
| $2.28M | ﹤0.01% |
23,721
+1,881
| +9% | +$199K |
|
3173
Marten Transport
MRTN
$1.24B
| $2.28M | ﹤0.01% |
145,838
+78,810
| +118% | +$1.16M |
|
3174
Viasat
VSAT
$11.4B
| $2.28M | ﹤0.01% |
34,661
+2,203
| +7% | +$141K |
|
|
QIWI
3175
DELISTED
QIWI PLC
QIWI
| $2.28M | ﹤0.01% |
144,556
+741
| +0.5% | +$12.7K |
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.